TEVA PHARMACEUTICAL INDUSTRIES LIMITED: accounts_receivable
| Value | {"amount": 6289000000, "concept": "us-gaap:AccountsReceivableNetCurrent", "currency": "USD"} |
|---|---|
| Period | (as of 2018-03-31) |
| Status | current |
| Entity | TEVA PHARMACEUTICAL INDUSTRIES LIMITED |
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
Retrieved: 2026-08-19T08:10:45.925207+02:00
Raw response sha256:
Also addressable by official identifiers:
Cite as: FACTANKER, https://factanker.com/fact/b63e5254-7c12-4baf-abc7-d460d60f74a9
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
0001193125-18-150803 · Open the official SEC filing →Retrieved: 2026-08-19T08:10:45.925207+02:00
Raw response sha256:
f7bde1a401b286c74a2fd824ee1df541…Also addressable by official identifiers:
https://factanker.com/fact/sec/cik-0000818686/accounts-receivable/2018-03-31 (CIK, metric, reporting date)Cite as: FACTANKER, https://factanker.com/fact/b63e5254-7c12-4baf-abc7-d460d60f74a9
History
- no predecessors — first report